Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma
Table 2
a. Characteristics of carcinoembryonic antigen (CEA), cancer antigen (CA) 125, CA19-9, and CA15-3 in 184 patients with advanced lung adenocarcinoma. b. Items of 163 patients with advanced lung adenocarcinoma with evaluable tumor markers.